ARN Physician Featured: What Does 2020 Hold for Biosimilars? Industry Experts Weigh In

Originally published in Biosimilar Development In the first installment of this four-part series, the members of the Biosimilar Development Editorial Board and friends discussed how 2019 turned out for the biosimilar industry. But as we face 2020, several big questions remain from the past year and about what the future may (or may not) bring […]

ARN Physician Featured: What Does 2020 Hold for Biosimilars? Industry Experts Weigh In Read More »